Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Spreading of Tumor”

11,717 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 11,717 results

Testing effectiveness (Phase 2)UnknownNCT03803436
What this trial is testing

Improving Outcome of Selected Patients With Non-resectable Hepatic Metastases From Colo-rectal Cancer With Liver Transplantation

Who this might be right for
Liver MetastasesColorectal Cancer MetastaticLiver Neoplasm+1 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 22
Not applicableStudy completedNCT02521571
What this trial is testing

The Resilience Alliance

Who this might be right for
Secondary Traumatic Stress
NYU Langone Health 357
Not applicableLooking for participantsNCT06833632
What this trial is testing

Detection of Circulating Tumour Cells, Spread Through Air Space in Patients With Lung Cancer

Who this might be right for
Non-Small-Cell Lung Cancer
IRCCS Azienda Ospedaliero-Universitaria di Bologna 100
Not applicableUnknownNCT05727033
What this trial is testing

Extraordinarily Fun Training Project in Compulsory Secondary Education - Sexually Transmitted Infections

Who this might be right for
Chlamydia InfectionsGonorrheaSyphilis Infection+3 more
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina 1,200
Large-scale testing (Phase 3)Study completedNCT04929249
What this trial is testing

Study to Evaluate the Effect of an "Inclisiran First" Implementation Strategy Compared to Usual Care in Patients With Atherosclerotic Cardiovascular Disease and Elevated LDL-C Despite Receiving Maximally Tolerated Statin Therapy (VICTORION-INITIATE)

Who this might be right for
Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals 450
Post-approval studies (Phase 4)Study completedNCT02953938
What this trial is testing

Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety

Who this might be right for
Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)
Novartis Pharmaceuticals 59
Testing effectiveness (Phase 2)UnknownNCT05969158
What this trial is testing

Hetrombopag in Secondary Prevention of XPO-1 Inhibitor-induced Thrombocytopenia in Lymphoma

Who this might be right for
Chemotherapy-Induced Thrombocytopenia
Sun Yat-sen University 90
Not applicableStudy completedNCT00858585
What this trial is testing

Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer: Concordance Study

Who this might be right for
Breast Cancer
University of Michigan Rogel Cancer Center 149
Not applicableLooking for participantsNCT02864485
What this trial is testing

Living Donor Liver Transplantation for Unresectable Colorectal Cancer Liver Metastases

Who this might be right for
Colorectal CancerLiver Metastases
University Health Network, Toronto 20
Early research (Phase 1)UnknownNCT05302843
What this trial is testing

BPI-28592 in Subjects With Advanced Solid Tumors

Who this might be right for
Metastasis, Neoplasm
Betta Pharmaceuticals Co., Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT03659136
What this trial is testing

The XENERA™ 1 Study Tests Xentuzumab in Combination With Everolimus and Exemestane in Women With Hormone Receptor Positive and HER2-negative Breast Cancer That Has Spread

Who this might be right for
Breast Neoplasms
Boehringer Ingelheim 103
Not applicableLooking for participantsNCT07297134
What this trial is testing

PTEN and Organ-Specific microRNAs in Metastatic Breast Cancer

Who this might be right for
Breast CancerMetastatic Breast CancermiRNAs+1 more
Atlas University 160
Testing effectiveness (Phase 2)Study completedNCT00724334
What this trial is testing

A Long-Term Study of the Effects of Orally Administered SAR302503 in Patients With Myelofibrosis

Who this might be right for
Myelofibrosis
Bristol-Myers Squibb 42
Not applicableStudy completedNCT02801409
What this trial is testing

Epidural Anesthesia-analgesia and Long-term Survival After Lung Cancer Surgery

Who this might be right for
Lung CancerThoracic SurgeryAnesthesia, Epidural+2 more
Peking University First Hospital 400
Not applicableStudy completedNCT06030232
What this trial is testing

Transarterial Radioembolization (TARE) in COlorectal MEtastasis of Liver

Who this might be right for
Transarterial Radioembolization
Ankara University 202
Testing effectiveness (Phase 2)Study completedNCT02650193
What this trial is testing

The Safety And Effects Of One Or More Doses Of HSP-130 Injected Under The Skin In Women With Breast Cancer That Has Not Spread To Distant Sites In The Body.

Who this might be right for
Non-metastatic Breast Cancer
Pfizer 25
Not applicableWithdrawnNCT04210726
What this trial is testing

Effect of Salt Solution Immersion Bath on Cancer in Vivo.

Who this might be right for
Cancer
Rafik Batroussy
Not applicableLooking for participantsNCT05793008
What this trial is testing

Characterization of priMary And sEcondary STress Related takOtsubo

Who this might be right for
Takotsubo CardiomyopathySepsis-induced Cardiomyopathy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 60
Not applicableStudy completedNCT04863625
What this trial is testing

Effects of a Peer-led Educational Intervention Based on Theory of Planned Behavior on Substance Use Intentions and Behaviors Among Secondary School Students of Dessie and Kombolcha Town, Northeast Ethiopia.

Who this might be right for
Substance Use
Wollo University 1,496
Testing effectiveness (Phase 2)Ended earlyNCT04171700
What this trial is testing

Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

Who this might be right for
Solid Tumor
pharmaand GmbH 83
Load More Results